Cargando…
miR-34a exerts as a key regulator in the dedifferentiation of osteosarcoma via PAI-1–Sox2 axis
Osteosarcoma (OS) is a malignant bone cancer with severe chromosomal abnormalities and genetic aberrations. Our previous work reported the dedifferentiation of OS, which is related to poor prognosis. However, the molecular mechanism that regulates OS dedifferentiation is still a subject of explorati...
Autores principales: | Zhang, Yu, Pan, Yubin, Xie, Chunyuan, Zhang, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039486/ https://www.ncbi.nlm.nih.gov/pubmed/29991717 http://dx.doi.org/10.1038/s41419-018-0778-4 |
Ejemplares similares
-
miR-126 Functions as a Tumor Suppressor in Osteosarcoma by Targeting Sox2
por: Yang, Chenglin, et al.
Publicado: (2013) -
Hydroxygenkwanin suppresses proliferation, invasion and migration of osteosarcoma cells via the miR-320a/SOX9 axis
por: Dong, Xinli, et al.
Publicado: (2022) -
Knockdown of MALAT1 inhibits osteosarcoma progression via regulating the miR‑34a/cyclin D1 axis
por: Duan, Guangchao, et al.
Publicado: (2018) -
Deregulation of MiR-34b/Sox2 Predicts Prostate Cancer Progression
por: Forno, Irene, et al.
Publicado: (2015) -
miR-34a targets PAI-1 to regulate urinary microalbumin and renal function in hypertensive mice
por: Liu, Ruitao, et al.
Publicado: (2020)